Literature DB >> 3106489

CD5 antibodies increase intracellular ionized calcium concentration in T cells.

C H June, P S Rabinovitch, J A Ledbetter.   

Abstract

The binding of a variety of monoclonal antibodies to the CD5 (T, gp67) pan T cell differentiation antigen has been shown to potentiate T cell proliferation. In this paper we show that CD5 monoclonal antibodies cause increased intracellular free calcium concentration ([Ca2+]i) in T cells. An increase in [Ca2+]i occurred within 1 min in indo-1-loaded PBMC after the addition of CD5 monoclonal antibodies and cross-linking with a second step anti-mouse kappa light chain antibody. Cross-linking of CD5 was effective when done directly on the cell surface or by the administration of preformed soluble complexes that contained CD5 antibodies. Calcium mobilization induced by suboptimal concentrations of CD3 antibodies was specifically augmented and sustained by CD5 antibodies, although the enhancement was modest in magnitude. When cell surface phenotype was correlated with calcium mobilization, it was found that the CD5 response was restricted to CD5+/CD3+ cells, and that approximately 90% of CD5+ cells had responded. CD5-induced calcium mobilization was found to differ from CD3 stimulation in that EGTA entirely ablated the CD5 response, whereas the CD3 response was resistant to EGTA, indicating that the CD5-induced increased [Ca2+]i is derived primarily or entirely from extracellular calcium. CD5-stimulated calcium mobilization also differed from CD3 in that the CD5 response was inhibited by pretreatment with phorbol myristate acetate, whereas the CD3 response was not, suggesting that depletion of protein kinase C causes an uncoupling of signal transduction between CD5 and calcium channels. Finally, experiments were done with T cells after antigenic modulation of the CD3 or CD5 molecules. Unexpectedly, both the CD5 and the CD3 responses were ablated on CD3-modulated cells, whereas only the CD5 response was ablated on CD5-modulated cells. In addition, several Cd5+/CD3- T cell leukemia lines also failed to respond to CD5 stimulation, providing further evidence which indicates that the CD5 response depends on the cell surface expression of CD3 or a CD3-associated structure. These findings suggest that one mechanism for CD5-induced augmentation of mitogen-stimulated T cell proliferation involves increased [Ca2+]i which is distinct from but interdependent with that induced by stimulation of the CD3 molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106489

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Stimulation of CD5 enhances signal transduction by the T cell antigen receptor.

Authors:  J B Imboden; C H June; M A McCutcheon; J A Ledbetter
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium.

Authors:  M Yamagami; P W McFadden; S M Koethe; V Ratanatharathorn; L G Lum
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  Identification of a molecule uniquely expressed on a gamma/delta TCR+ subset within bovine intestinal intraepithelial lymphocytes.

Authors:  K R Parsons; P Sopp; B V Jones; P Bland; C J Howard
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

6.  Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa.

Authors:  L K Trejdosiewicz; C J Smart; D J Oakes; P D Howdle; G Malizia; D Campana; A W Boylston
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

7.  Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.

Authors:  B E Bierer; Y Nishimura; S J Burakoff; B R Smith
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

8.  Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes.

Authors:  S I Gringhuis; L F de Leij; P J Coffer; E Vellenga
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

9.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

10.  CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.

Authors:  K E Burgess; M Yamamoto; K V Prasad; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.